IgM-enriched Intravenous Immunoglobulins (Medical University of Vienna)

静脉注射免疫球蛋白M

Report date: 2025/03/07 17:34:45

Base Information

Drug NameIgM-enriched Intravenous Immunoglobulins (Medical University of Vienna)
Drug Alias NamePentaglobin biosimilar
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood componentsBiologics > Biosimilar
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAmyloid NeuropathiesMyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedical University Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAmyloid NeuropathiesMyositis

Other Information

ATC CodeN/A
Related LinksN/A